Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Holding EMBC?
Track your performance easily
EMBC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.93 - $19.79
Previous Close$14.41
Volume1.87M
Average Volume (3M)363.70K
Market Cap
$831.48M
Enterprise Value$2.19B
Total Cash (Recent Filing)$275.10M
Total Debt (Recent Filing)$1.63B
Price to Earnings (P/E)11.9
Beta0.88
Next Earnings
Nov 26, 2024EPS Estimate
$0.36Last Dividend Ex-Date
Aug 27, 2024Dividend Yield4.34%
Share Statistics
EPS (TTM)1.21
Shares Outstanding57,701,830
10 Day Avg. Volume348,232
30 Day Avg. Volume363,696
Standard Deviation0.14
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.03
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)-92.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.96
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda14.50
Forecast
1Y Price Target
$13.00Price Target Upside-30.48% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Embecta Corporation News
Bulls Say, Bears Say
Bulls Say
FDA ApprovalManagement was pleased with recent FDA approval of EMBC's open loop system.
Market ExpansionPlans are in place to offer similar deals in more countries across Europe.
Product InnovationThe pump contains a 300-unit insulin reservoir which can accommodate those who have higher daily insulin needs, typically those with T2D.
Bears Say
Competitive EnvironmentThe majority of conversations with investors about the pump program are negative due to high establishment costs and an intensifying competitive environment.
Financial ProjectionsForward Street numbers are not fully accounting for the probable costs associated with the closed loop project, nor any potential revenue.
Program ExpectationsSome investors had hoped that EMBC would scrap the pump program altogether.
---
Ownership Overview
1.59% Insiders
29.66% Mutual Funds
24.01% Other Institutional Investors
16.51% Public Companies and
Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $19.79 in the past 12 months.
What is Embecta Corporation’s market cap?
Currently, no data Available
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is Nov 26, 2024 which is yesterday.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Aug 09, 2024. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.464 by $0.276.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Overvalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 4.34%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is $0.36.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 57,701,830 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.74 in its last earnings report, beating expectations of $0.464. Following the earnings report the stock price went up 7.329%.
Which hedge fund is a major shareholder of Embecta Corporation?
Among the largest hedge funds holding Embecta Corporation’s share is Deerfield Management Company, LP. It holds Embecta Corporation’s shares valued at 38M.
---
Embecta Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$13.00 (-30.48% Downside)
$13.00 (-30.48% Downside)
Blogger Sentiment
Bullish
EMBC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 385.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.3%
Last 30 Days ▲ 51.9%
Last 30 Days ▲ 51.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.17%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.23%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q3 2024
0:00 / 0:00
---
EMBC Stock 12 Month Forecast
Average Price Target
$13.00
▼(-30.48% Downside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+17.73%
assigned a sell rating 3 months ago
Copying Kallum Titchmarsh's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +17.73% per trade.
---